Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-06 · accession 0001801170-25-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-08 | 2025-01-06 | CLOV | Kouzoukas Demetrios L. | Dir | A - Grant | $0.00 | +61.0K | 526.6K | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-06 | A | A | 60,975 | $0.00 | 526,615 | D | — | — | (F1) Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. |